Published in J Am Acad Dermatol on May 01, 2006
Adherence to Oral and Topical Medications in Cutaneous Lupus Erythematosus is not Well Characterized. Dermatol Ther (Heidelb) (2015) 0.75
Patient adherence with treatment. J Am Acad Dermatol (2007) 0.75
Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol (2010) 8.55
Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol (2008) 3.95
US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis (2015) 3.94
Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women: an observational study. Lancet (2002) 3.88
Measuring patients' trust in their primary care providers. Med Care Res Rev (2002) 3.43
Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc (2004) 3.40
Skin cancer is among the most costly of all cancers to treat for the Medicare population. J Am Acad Dermatol (2003) 3.22
Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol (2005) 3.04
Adherence, the fourth dimension in the geometry of dermatological treatment. Arch Dermatol (2009) 2.91
In the United States, blacks and Asian/Pacific Islanders are more likely than whites to seek medical care for atopic dermatitis. Arch Dermatol (2002) 2.75
Increased physician-reported sleep apnea: the National Ambulatory Medical Care Survey. Chest (2002) 2.65
Trust in the medical profession: conceptual and measurement issues. Health Serv Res (2002) 2.46
The burden of atopic dermatitis: impact on the patient, family, and society. Pediatr Dermatol (2005) 2.26
Mental health and quality of life of gay men and lesbians in England and Wales: controlled, cross-sectional study. Br J Psychiatry (2003) 2.20
Quality of life among younger women with breast cancer. J Clin Oncol (2005) 2.19
Adjuvant hormonal therapy use among insured, low-income women with breast cancer. J Clin Oncol (2009) 2.14
Attention network hypoconnectivity with default and affective network hyperconnectivity in adults diagnosed with attention-deficit/hyperactivity disorder in childhood. JAMA Psychiatry (2013) 2.11
Willing to wait?: the influence of patient wait time on satisfaction with primary care. BMC Health Serv Res (2007) 2.10
A 50% reduction in the Psoriasis Area and Severity Index (PASI 50) is a clinically significant endpoint in the assessment of psoriasis. J Am Acad Dermatol (2004) 2.05
Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions. J Am Acad Dermatol (2011) 2.03
Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics. J Am Acad Dermatol (2008) 1.99
Determinants of quality of life in patients with psoriasis: a study from the US population. J Am Acad Dermatol (2004) 1.94
Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies. J Am Acad Dermatol (2009) 1.94
Interleukin-12, interleukin-23, and psoriasis: current prospects. J Am Acad Dermatol (2007) 1.76
Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents. J Am Acad Dermatol (2009) 1.76
Measuring trust in medical researchers. Med Care (2006) 1.69
The prevalence of psoriasis in African Americans: results from a population-based study. J Am Acad Dermatol (2005) 1.68
Switching from prescription to over-the counter medications: a consumer and managed care perspective. Manag Care Interface (2007) 1.67
Adherence in dermatology: a review of the last 20 years. J Dermatolog Treat (2006) 1.64
The importance of medication adherence in improving chronic-disease related outcomes: what we know and what we need to further know. Med Care (2005) 1.64
Development and validation of the insulin treatment satisfaction questionnaire. Clin Ther (2004) 1.62
Factors associated with herbal use among urban multiethnic primary care patients: a cross-sectional survey. BMC Complement Altern Med (2004) 1.60
A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis. J Am Acad Dermatol (2006) 1.59
Attitudes of African American and low socioeconomic status white women toward medical research. J Health Care Poor Underserved (2007) 1.58
Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis. Clin Ther (2007) 1.58
Drug samples in dermatology: special considerations and recommendations for the future. J Am Acad Dermatol (2010) 1.55
Psychosocial problems among younger women with breast cancer. Psychooncology (2004) 1.55
Pyoderma gangrenosum: a review and update on new therapies. J Am Acad Dermatol (2010) 1.53
Effect of injury severity on the incidence and utilization-related outcomes of venous thromboembolism in pediatric trauma inpatients. Pediatr Crit Care Med (2009) 1.52
Burden associated with chronic sleep maintenance insomnia characterized by nighttime awakenings among women with menopausal symptoms. Menopause (2010) 1.52
Written action plans: potential for improving outcomes in children with atopic dermatitis. J Am Acad Dermatol (2008) 1.52
Eligibility creep: a cause for placebo group improvement in controlled trials of psoriasis treatments. J Am Acad Dermatol (2007) 1.51
A randomized controlled pilot study of the effects of an extra office visit on adherence and outcomes in atopic dermatitis. Arch Dermatol (2010) 1.50
Cost-effectiveness of biologic treatments for psoriasis based on subjective and objective efficacy measures assessed over a 12-week treatment period. J Am Acad Dermatol (2007) 1.50
Effect on survival of longer intervals between confirmed diagnosis and treatment initiation among low-income women with breast cancer. J Clin Oncol (2012) 1.49
Complex aphthosis: a large case series with evaluation algorithm and therapeutic ladder from topicals to thalidomide. J Am Acad Dermatol (2005) 1.49
Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy. J Am Acad Dermatol (2009) 1.48
UV light abuse as a substance-related disorder: clinical implications. Arch Dermatol (2008) 1.48
Evaluation of the quality of care in the clinical care centers of the National Centers of Excellence in Women's Health. Womens Health Issues (2002) 1.46
Demand for continuing medical education programs on cancer care among primary care physicians in North Carolina. N C Med J (2004) 1.46
Tacrolimus ointment is effective for facial and intertriginous psoriasis. J Am Acad Dermatol (2004) 1.45
Members of the national psoriasis foundation: more extensive disease and better informed about treatment options. Arch Dermatol (2005) 1.45
Economic evaluation of carotid artery stenting versus carotid endarterectomy for the treatment of carotid artery stenosis. J Am Coll Surg (2007) 1.44
Trends in pediatric psoriasis outpatient health care delivery in the United States. Arch Dermatol (2011) 1.44
Stealth monitoring of adherence to topical medication: adherence is very poor in children with atopic dermatitis. J Am Acad Dermatol (2006) 1.44
Hyperpigmentation: an overview of the common afflictions. Dermatol Nurs (2004) 1.43
Treatment of psoriasis in children: is there a role for antibiotic therapy and tonsillectomy? Pediatr Dermatol (2003) 1.43
Dermatosis neglecta: a series of case reports and review of other dirty-appearing dermatoses. Dermatol Online J (2006) 1.42
Cutaneous symptoms of dermatomyositis significantly impact patients' quality of life. J Am Acad Dermatol (2005) 1.42
Trends in Mohs surgery from 1995 to 2010: an analysis of nationally representative data. Dermatol Surg (2015) 1.42
An open-label pilot study to evaluate the safety and efficacy of topically applied tacrolimus ointment for the treatment of hand and/or foot eczema. J Dermatolog Treat (2003) 1.40
Induction of withdrawal-like symptoms in a small randomized, controlled trial of opioid blockade in frequent tanners. J Am Acad Dermatol (2006) 1.40
How much of a topical agent should be prescribed for children of different sizes? J Dermatolog Treat (2006) 1.40
Where did current academic dermatologists train? J Am Acad Dermatol (2010) 1.39
Increase in procedures performed at dermatology office visits from 1995 to 2001. Dermatol Surg (2005) 1.39
Phototherapy trends in dermatology. J Dermatolog Treat (2013) 1.38
US Renal Data System 2015 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis (2016) 1.37
Rates and predictors of mental illness in gay men, lesbians and bisexual men and women: Results from a survey based in England and Wales. Br J Psychiatry (2004) 1.36
Use of electronic medical records differs by specialty and office settings. J Am Med Inform Assoc (2013) 1.34
Extended efalizumab therapy improves chronic plaque psoriasis: results from a randomized phase III trial. J Am Acad Dermatol (2005) 1.34
Poor adherence to treatments: a fundamental principle of dermatology. Arch Dermatol (2007) 1.34
Breast cancer screening, area deprivation, and later-stage breast cancer in Appalachia: does geography matter? Health Serv Res (2013) 1.32
Quality of life in patients with psoriasis. Health Qual Life Outcomes (2006) 1.31
Psoriasis: improving adherence to topical therapy. J Am Acad Dermatol (2008) 1.28
Race and medication adherence in Medicaid enrollees with type-2 diabetes. J Natl Med Assoc (2006) 1.27
Patients with psoriasis prefer solution and foam vehicles: a quantitative assessment of vehicle preference. Cutis (2002) 1.27
The safety of liposuction: results of a national survey. Dermatol Surg (2002) 1.25
Pharmacoeconomic considerations in treating actinic keratosis. Pharmacoeconomics (2009) 1.24
Optimizing topical therapies for treating psoriasis: a consensus conference. Cutis (2010) 1.22
Patient injuries from surgical procedures performed in medical offices: three years of Florida data. Dermatol Surg (2004) 1.20
The economic impact of non-melanoma skin cancer: a review. J Natl Compr Canc Netw (2010) 1.20
The effect of reminder systems on patients' adherence to treatment. Patient Prefer Adherence (2012) 1.19
Hydroxyurea adherence and associated outcomes among Medicaid enrollees with sickle cell disease. Am J Hematol (2011) 1.19
Health care utilization in patients with migraine: demographics and patterns of care in the ambulatory setting. Headache (2003) 1.19
Microtubule-associated protein 2, a marker of neuronal differentiation, induces mitotic defects, inhibits growth of melanoma cells, and predicts metastatic potential of cutaneous melanoma. Am J Pathol (2005) 1.19